4.7 Article

Unprecedented Citrinin Trimer Tricitinol B Functions as a Novel Topoisomerase IIα Inhibitor

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 16, 页码 5796-5810

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm200511x

关键词

-

资金

  1. Chinese National Science Fund [30973627]
  2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  3. Natural Science Foundation of China for Distinguished Young Scholars [30725046]
  4. National Science & Technology Major Project Key New Drug Creation and Manufacturing Program [2009ZX09301-001, 2009ZX09103-045]
  5. Program of Shanghai Subject Chief Scientist [10XD1405100]
  6. Science and Technology Planning Project of Shandong Province, China [2010GSF10216]
  7. program for Changjiang Scholars and Innovative Research Team in University [IRT0944]

向作者/读者索取更多资源

Fifteen citrinin derivatives (1-4,6-16), including two unprecedented citrinin timers tricitrinols A (3) and B (4), were isolated from Penicillium citrinum HGY1-5. The six-membered ring A system is essential for the cytotoxicity of active dimers (1, 2, and 5) and trimers (3 and 4). Tricitrinol B (4) showed extensive cytotoxicity in 17 tumor cells with comparable low-micromolar IC50 values (1-10 mu M) and potential antimultidrug resistance capabilities. Tricitrinol B (4) induced cell apoptosis in HL60 and HCT116 cells via mainly extrinsic pathways and G2/M arrest. Further antitumor mechanism study and computational docking analysis indicated that tricitrinol B (4) works as an intercalating topoisomerase II alpha (topo II alpha) poison, which inhibits the enzyme activity of topo II alpha by interfering predominantly with the topo II alpha-mediated poststrand-passage deavage/religation equilibrium over with the prestrand-passage one and induced DNA damage. Tricitrinol B (4) represents a novel class of topo II alpha-inhibitory skeletons for developing new chemotherapeutic agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据